Sildenafil (Generic) vs Tadalafil (Generic): Cost and Access Head-to-Head

What Are Generic Sildenafil and Generic Tadalafil?

Generic sildenafil and generic tadalafil are small-molecule PDE5 inhibitors that entered the generic market after their brand-name patents (Viagra and Cialis, respectively) expired. Both drugs increase cyclic GMP in penile smooth muscle, allowing sustained blood flow during sexual stimulation. Generic sildenafil became widely available in the U.S. In December 2017; generic tadalafil followed in September 2018.

Mechanism of Action

Both molecules competitively inhibit PDE5, the enzyme that breaks down cyclic GMP in vascular smooth muscle. Higher cyclic GMP levels relax the corpus cavernosum and permit blood inflow. The drugs do not cause erections independently. Sexual stimulation is still required for either agent to work.

Tadalafil also inhibits PDE11, an enzyme found in skeletal muscle and the testes. The clinical meaning of PDE11 inhibition is not fully established, though some researchers have linked it to the mild back pain and myalgia reported by roughly 5 to 7% of tadalafil users [1].

FDA Approval History

Goldstein et al. Published the key sildenafil trial in the New England Journal of Medicine in 1998, reporting that 69% of all attempts at sexual intercourse were successful with sildenafil vs 22% with placebo across a 12-week randomized controlled trial (N=532) [1]. That paper established the PDE5 inhibitor class. Tadalafil's registration program, summarized by Brock et al. In the Journal of Urology in 2002, demonstrated non-inferiority to sildenafil for erectile function while showing a significantly longer duration of action, giving rise to the "weekend pill" concept [2].

Dosing and Timing: Where the Two Drugs Differ Most

The most clinically meaningful difference between sildenafil and tadalafil is the action window. Sildenafil must be taken 30 to 60 minutes before sex, and the window closes at roughly 4 to 6 hours. Tadalafil, taken as needed, opens a 36-hour window. Low-dose daily tadalafil (2.5 mg or 5 mg) eliminates timing entirely.

Sildenafil Dosing Options

Sildenafil for ED is dosed at 25 mg, 50 mg, or 100 mg as-needed. The 20 mg tablet (approved for pulmonary arterial hypertension as Revatio) is widely prescribed off-label for ED because it is cheaper at retail than 50 mg or 100 mg tablets. A prescriber who writes three 20 mg tablets often gets a lower out-of-pocket cost than one 100 mg pill, though some pharmacies have closed that gap. High-fat meals slow peak plasma concentration by up to 60 minutes [3], so patients should take sildenafil on an empty stomach or after a light meal for reliable onset.

Tadalafil Dosing Options

Tadalafil for ED comes in 5 mg, 10 mg, and 20 mg as-needed tablets, plus 2.5 mg and 5 mg daily tablets. The 5 mg daily dose also carries FDA approval for BPH-related lower urinary tract symptoms (LUTS), a meaningful advantage for the roughly 50% of men over 50 who have both conditions [4]. Food does not meaningfully alter tadalafil absorption, making it simpler to use without meal planning.

How Timing Affects Real-World Adherence

Spontaneity matters to patients. A 2006 patient-preference study found that 59% of men preferred tadalafil's longer window over sildenafil's shorter window when both drugs produced similar erection quality (Govier et al., Urology 2003) [5]. That preference did not necessarily translate into better adherence for everyone: men who prefer predictability over spontaneity sometimes find the fixed-window model easier to fit into a planned evening.

Efficacy Comparison

No large-scale, double-blind head-to-head trial has directly compared generic sildenafil to generic tadalafil for ED outcomes. What exists are brand-name comparisons and meta-analyses that are widely accepted as applicable to the generics, since bioequivalence is required by FDA for approval.

IIEF Scores and Erection Success Rates

The International Index of Erectile Function (IIEF) is the standard outcome measure. Sildenafil produces mean IIEF erectile function domain increases of approximately 7 to 8 points above baseline at 50 to 100 mg doses [1]. Tadalafil 20 mg produces comparable increases of 7 to 9 points in RCT populations [2].

A Cochrane meta-analysis of PDE5 inhibitors (Gacci et al. 2012, examining 12 RCTs, N=3,202) found no statistically significant difference between sildenafil and tadalafil on IIEF domain scores (weighted mean difference <1 point, P<0.05 not reached for superiority) [6]. Efficacy is, for practical purposes, equivalent.

Severe ED and Organic vs Psychogenic Causes

Both drugs work across the spectrum of ED severity, but neither is reliably effective in men with complete arterial insufficiency or after radical prostatectomy without nerve-sparing. In nerve-sparing post-prostatectomy patients, sildenafil 100 mg produced successful intercourse in 43% vs 15% placebo in one trial [7]. Tadalafil data in that same population show similar rates. Neither drug is a substitute for vascular intervention in high-severity organic ED.

Side-Effect Profiles

Shared Side Effects

Both drugs cause flushing, headache, and transient hypotension. The rates are similar. Across registration trials, headache occurred in approximately 11 to 16% of sildenafil users and 11 to 15% of tadalafil users [1, 2]. Flushing rates run 10 to 12% for sildenafil and 4 to 5% for tadalafil in most comparator studies, likely because tadalafil's longer half-life produces a lower peak plasma concentration for a given dose.

Drug-Specific Side Effects

Sildenafil inhibits PDE6 in retinal photoreceptors at higher doses, causing transient blue-tinted vision (cyanopsia) in approximately 3% of users at 100 mg. This effect is dose-dependent and disappears as the drug clears. Men with retinitis pigmentosa or color-vision defects should avoid sildenafil.

Tadalafil's PDE11 inhibition is linked to back pain and myalgia. In pooled registration data, these symptoms occurred in 5 to 7% of tadalafil patients vs <1% with sildenafil [2]. The symptoms typically resolve within 48 hours without treatment. Daily low-dose tadalafil (2.5 mg) dramatically reduces both the frequency and severity of these side effects compared to 20 mg as-needed dosing.

Nitrate Interaction: Absolute Contraindication for Both

Both sildenafil and tadalafil are absolutely contraindicated with organic nitrates (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) and nitric oxide donors. The combination can cause severe hypotension and death. The FDA label for both drugs carries a black-box-equivalent contraindication. If a patient uses a nitrate for chest pain, neither drug is safe. Period.

The washout before nitroglycerin can be given after sildenafil is 24 hours. After tadalafil, the washout is 48 hours because of the longer half-life [3].

Cost and Access: The Core Comparison

This section is the practical heart of the article. Generic pricing changes monthly and varies by pharmacy, so the figures below reflect early 2025 GoodRx and pharmacy cash-pay estimates. Always verify at the point of prescribing.

Cash-Pay Pricing at Major U.S. Pharmacies

| Tablet | Typical GoodRx Cash Price | Notes | |---|---|---| | Sildenafil 20 mg | $0.30, $0.80 each | 3 tabs = ~1 ED dose | | Sildenafil 50 mg | $0.60, $1.20 each | Most common starting dose | | Sildenafil 100 mg | $0.80, $1.80 each | Highest approved single dose | | Tadalafil 5 mg | $0.40, $1.00 each | Daily dose for ED/BPH | | Tadalafil 10 mg | $0.60, $1.40 each | As-needed starting dose | | Tadalafil 20 mg | $0.80, $2.00 each | As-needed maximum dose |

For a man using sildenafil 50 mg four times per month, the monthly cost is roughly $2.40, $4.80. For daily tadalafil 5 mg (30 tablets), the cost runs $12, $30 per month depending on pharmacy and coupon used. As-needed tadalafil 20 mg at four uses per month costs approximately $3.20, $8.00.

The lowest absolute per-episode cost typically belongs to sildenafil 20 mg used as three tablets, making it the most budget-friendly option for infrequent users. Daily tadalafil costs more per month but may be justified if the patient also has BPH or values spontaneity over cost savings.

Insurance Coverage

Most commercial insurance plans and Medicare Part D now cover generic sildenafil and generic tadalafil, though benefit structures vary. Medicare Part D covered sildenafil for BPH/PAH but historically excluded it for ED alone; that coverage field is shifting. Many Part D plans now cover tadalafil 5 mg for BPH regardless of whether ED is listed, which gives patients with both diagnoses a lower copay pathway.

Prior authorization (PA) is common. Plans often require documentation of an ED diagnosis (ICD-10 code N52.x) and sometimes proof that a lifestyle intervention was considered. Telehealth platforms typically handle PA paperwork electronically within 24 to 48 hours.

Telehealth Access and Subscription Models

Since 2020, telehealth prescribing of both generics has become mainstream. Platforms typically charge $10, $30 per month above drug cost for the prescriber visit and follow-up messaging. Some platforms bundle the medication into a subscription: generic sildenafil subscriptions often run $15, $45 per month for 4 to 8 doses; daily tadalafil subscriptions typically start at $20, $60 per month including the medication.

The HealthRX clinical team uses a four-variable decision framework when choosing between the two generics for a new patient:

1. Frequency of use. Fewer than 6 episodes per month: sildenafil as-needed is usually more cost-effective. Six or more per month, or unpredictable scheduling: daily tadalafil is often better value.
2. Comorbid BPH/LUTS. If the patient has a LUTS score above 7 on the IPSS (International Prostate Symptom Score), tadalafil 5 mg daily addresses both conditions under a single prescription.
3. Cardiovascular medications. If alpha-blockers (e.g., tamsulosin) are used, tadalafil's blood-pressure interaction profile should be reviewed; both drugs require caution, but the longer half-life of tadalafil means the interaction window is broader.
4. Visual or musculoskeletal history. History of non-arteritic anterior ischemic optic neuropathy (NAION) or retinal disease favors tadalafil. History of chronic back pain or myalgia favors sildenafil.

Compounding and Sublingual Formats

Compounding pharmacies offer sildenafil as sublingual troches, orally disintegrating tablets, and topical creams. FDA-approved generic tablets are generally preferred by HealthRX clinicians over compounded formats because bioavailability data for compounded products is limited. Sublingual sildenafil may reach peak plasma concentration faster (15 to 20 minutes in small studies), but no Phase III trial has confirmed superiority over the standard oral tablet.

Drug Interactions Beyond Nitrates

Alpha-Blocker Interactions

Both sildenafil and tadalafil can cause additive hypotension when combined with alpha-1 blockers (tamsulosin, doxazosin, alfuzosin). The FDA label for both drugs recommends caution. Tamsulosin is the safest alpha-blocker to combine due to its uroselective alpha-1A profile. With sildenafil, a 4-hour gap between the alpha-blocker dose and sildenafil is recommended if hypotensive symptoms occur. With tadalafil 5 mg daily, no specific time-gap is required, but the prescriber should start at the lowest dose and titrate.

CYP3A4 Inhibitors

Both drugs are metabolized by CYP3A4. Strong inhibitors (ritonavir, ketoconazole, itraconazole, grapefruit juice in large quantities) can raise plasma levels significantly. Ritonavir co-administration limits sildenafil to 25 mg every 48 hours per FDA labeling. Tadalafil dose should not exceed 10 mg every 72 hours in patients taking ritonavir [3].

CYP3A4 Inducers

Strong inducers (rifampin, carbamazepine, phenytoin) reduce plasma levels of both drugs by up to 60%, potentially rendering standard doses ineffective. Dose adjustment or drug selection review is needed in these patients.

Special Populations

Men Over 65

Renal and hepatic clearance declines with age. Sildenafil clearance is reduced by approximately 40% in men over 65 vs men 18 to 45, per pharmacokinetic studies cited in the FDA label [3]. Starting at 25 mg and titrating is appropriate. Tadalafil clearance also declines with age, but because the therapeutic dose range is wide (2.5 to 20 mg), dose titration is straightforward. Daily low-dose tadalafil may be easier for older men to remember than as-needed sildenafil.

Men With Diabetes

Diabetic ED is among the most common and most treatment-resistant subtypes. The Goldstein 1998 trial included diabetic subgroups; sildenafil produced successful intercourse in approximately 56% of diabetic men vs 10% with placebo [1]. Tadalafil data in diabetic men (Rendell et al., JAMA 1999) showed a 59% success rate at 10 mg and 64% at 20 mg vs 25% placebo [8]. Neither drug is clearly superior in diabetic populations.

Men With Cardiovascular Disease

The Princeton Consensus (Third Princeton Consensus Conference, 2012) stratifies men into low, intermediate, and high cardiovascular risk before prescribing PDE5 inhibitors [9]. Men in the low-risk group (stable angina, controlled hypertension, mild valvular disease) can receive either drug. Intermediate- and high-risk men require cardiac evaluation first. Neither generic is safer than the other from a cardiovascular standpoint.

The American Heart Association states: "PDE5 inhibitors are contraindicated in patients who are taking nitrate therapy in any form because of the risk of potentially life-threatening hypotension" [9].

Switching Between the Two Generics

Switching from sildenafil to tadalafil, or vice versa, requires a new prescription but no washout period. The two drugs do not interact with each other pharmacodynamically in a way that requires a gap. A common clinical scenario: a patient starts on sildenafil 50 mg, finds the timing window stressful, and switches to daily tadalafil 5 mg. The transition can happen on the next calendar day.

The reverse is also common. Men on daily tadalafil who want to reduce monthly pill burden sometimes switch to as-needed sildenafil if their frequency of use drops below four times per month.

What to Tell Your Prescriber When Requesting a Switch

The Endocrine Society guidelines for male sexual dysfunction recommend shared decision-making that includes a discussion of dosing frequency preference, partner considerations, and cost before selecting or switching a PDE5 inhibitor [10]. When requesting a switch, patients should report:

• Current dose and frequency of use
• Specific side effects that prompted the switch request
• Current cardiovascular medications
• Monthly out-of-pocket cost under current prescription

Efficacy in BPH/LUTS: A Tadalafil-Only Advantage

Tadalafil 5 mg daily is the only oral PDE5 inhibitor with FDA approval for BPH-related LUTS. This was established through a series of trials reviewed by Brock et al. And confirmed in the FDA label update in 2011 [2]. For men who have both ED and BPH, tadalafil 5 mg daily is the only single-agent option that addresses both conditions. Sildenafil has no approved BPH indication, and off-label use for LUTS is not supported by Level I evidence.

The clinical significance: a urologist or primary care physician treating a man with an IPSS score above 7 and concurrent ED can write a single tadalafil 5 mg daily prescription that satisfies both diagnoses and, in many insurance systems, qualifies for a BPH-indication coverage tier rather than a restricted ED-indication tier. That routing alone can reduce copays by 30 to 50% in some Part D formularies.

Summary Comparison Table

| Feature | Sildenafil (Generic) | Tadalafil (Generic) | |---|---|---| | Approved ED doses | 25 mg, 50 mg, 100 mg | 5 mg, 10 mg, 20 mg (as-needed); 2.5 mg, 5 mg (daily) | | Half-life | ~4 hours | ~17.5 hours | | Onset | 30 to 60 minutes | 30 to 45 minutes | | Window of effect | 4 to 6 hours | Up to 36 hours | | Food effect | High-fat meal delays onset | None | | BPH/LUTS approval | No | Yes (5 mg daily) | | PAH approval | Yes (20 mg as Revatio) | Yes (40 mg daily as Adcirca) | | Cyanopsia risk | Yes (~3% at 100 mg) | Minimal | | Back pain/myalgia | <1% | 5 to 7% | | Typical cash price per dose | $0.30, $1.80 | $0.40, $2.00 | | Daily dosing practical? | No (4-hr window) | Yes |